Showing results (171-180 of 492) with videos related to
Sort By:
Pageof 50
Journal of Viral Hepatitis|November 25, 2021
The impact of the first, second and third waves of covid-19 on hepatitis B and C testing in Ontario, CanadaErin Mandel, Adriana Peci, Kirby Cronin, et al.Hepatology (Baltimore, Md.)|September 8, 2011
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patientsBirgit Edlich, Golo Ahlenstiel, Aintzane Zabaleta Azpiroz, et al.European Journal of Public Health|June 29, 2011
Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesisRoss J Harris, Mary Ramsay, Vivian D Hope, et al.Hepatology (Baltimore, Md.)|September 8, 2011
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populationsNatasha K Martin, Peter Vickerman, Alec Miners, et al.Cytokine|May 7, 2002
Different activities of type I interferons on hepatitis B virus core promoter regulated transcriptionEwert Schulte-Frohlinde, Barbara Seidler, Ines Burkard, et al.United European Gastroenterology Journal|June 12, 2014
A cross sectional study of colonic diverticulosis in the London Bangladeshi populationRajiv P Lahiri, Aliza Abeles, Katherine M Burnand, et al.Gut|May 3, 2015
The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infectionMahmoud Abu-Amara, Orlando Cerocchi, Gurtej Malhi, et al.Canadian Liver Journal|August 22, 2022
The 9th Canadian Symposium on Hepatitis C Virus: Advances in HCV research and treatment towards eliminationJiafeng Li, Julia L Casey, Zoë R Greenwald, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseasesAndrew S Artz, Mark R Somerfield, Jordan J Feld, et al.Gastroenterology|January 30, 2007
Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis CYing Huang, Jordan J Feld, Ronda K Sapp, et al.Pageof 50